Efficacy of almitrine as a rescue therapy for refractory hypoxemia in COVID and non-COVID acute respiratory distress syndrome. A retrospective monocenter study.
Sign Up to like & getrecommendations! Published in 2022 at "Minerva anestesiologica"
DOI: 10.23736/s0375-9393.22.16736-2
Abstract: BACKGROUND Almitrine, a drug enhancing hypoxic pulmonary vasoconstriction, has been proposed as a rescue therapy for refractory hypoxemia in Covid related Acute Respiratory Distress Syndrome (C-ARDS). We aimed at investigating the response to almitrine depending… read more here.
Keywords: refractory hypoxemia; almitrine; covid; almitrine infusion ... See more keywords